For subscribers
Anwar’s administration faces test in dealing with troubled GLC Pharmaniaga
Sign up now: Get insights on the biggest stories in Malaysia
The Malaysian pharma giant has 14 million unused Sinovac vaccines that has pulled down its finances.
PHOTO: ST FILE
Follow topic:
KUALA LUMPUR - Malaysia’s pharmaceutical firm Pharmaniaga is hoping for government help to sell its massive Covid-19 vaccine stockpile, in what could be a litmus test for the four-month-old Anwar Ibrahim administration in managing troubled government-linked companies (GLCs).
During the pandemic, the Malaysian government directly bought Pfizer and AstraZeneca vaccines from manufacturers. The government also allowed Pharmaniaga to exclusively import Sinovac vaccines from China. Malaysia also took part in the Covax programme supported by World Health Organisation to buy vaccines.
